Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-32,200
Closed -$1.67M 3712
2018
Q1
$1.67M Sell
32,200
-36,000
-53% -$2.13M ﹤0.01% 2165
2017
Q4
$4.17M Sell
68,200
-53,600
-44% -$3.41M 0.01% 1619
2017
Q3
$6.72M Buy
121,800
+11,400
+10% +$579K 0.01% 1177
2017
Q2
$4.69M Buy
110,400
+81,800
+286% +$3.63M 0.01% 1392
2017
Q1
$1.2M Buy
+28,600
New +$1.05M ﹤0.01% 2187
2014
Q2
Sell
-29,400
Closed -$498K 4219
2014
Q1
$498K Buy
+29,400
New +$549K ﹤0.01% 3620
2013
Q4
Sell
-176,000
Closed -$2.76M 4469
2013
Q3
$2.76M Buy
+176,000
New +$2.46M ﹤0.01% 2143

Other funds holding CGNX

David Shaw's CGNX Position: Q2 2026 in Review

David Shaw increased its Cognex (CGNX) stake by 971% in Q2 2026, buying an estimated $5.59M and bringing the position to 101,700 shares worth $7.37M. The position accounts for ﹤0.01% of the portfolio, ranked #2094.

David Shaw first reported a position in CGNX in Q2 2013 and has held it in 38 quarters since. The position peaked at $56.1M in Q2 2021. 649 funds tracked by Wall St. Rank hold CGNX as of Q2 2026.

  • David Shaw held 101,700 shares of Cognex worth $7.37M as of Q2 2026.
  • David Shaw bought 92,205 Cognex shares in Q2 2026, an estimated $5.59M.
  • Cognex made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2094 holding.
  • David Shaw first reported a position in Cognex in Q2 2013 and has held it in 38 quarters since.
  • David Shaw's Cognex position peaked at $56.1M in Q2 2021.
  • 649 funds tracked by Wall St. Rank held Cognex as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.